Financhill
Back

Cytokinetics Stock Predictions

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 13.6% based on the past 19 years of stock performance.
  • Cytokinetics has risen higher in 11 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $67.00. The Score for CYTK is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 13.6% based on the past 19 years of stock performance.

Cytokinetics Stock Rating

Buy
56
Cytokinetics (CYTK) is a Buy

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 11 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
110.25
52-Week Low:
25.98

Prediction Charts

Market Cap:
6.9B
Price in USD:
67.00
Volume:
746.27K
Beta:
1.46

Technical Analysis

SMA50:
71.47
SMA100:
67.53
SMA200:
50.31
52-Wk Change:
82.07%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 67.00 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-1 69.78 73.09 73.16 68.90
Apr-2 71.19 70.97 72.72 70.35
Apr-3 70.27 70.95 71.43 70.00
Apr-4 71.69 69.21 72.33 68.72
Apr-5 69.21 72.71 73.21 68.43
Apr-8 73.90 74.19 74.38 72.55
Apr-9 74.20 75.05 75.71 73.43
Apr-10 72.54 74.36 75.00 72.28
Apr-11 74.99 73.26 75.50 72.35
Apr-12 73.76 71.60 73.76 70.61
Apr-15 71.60 68.01 71.60 67.45
Apr-16 67.81 68.95 70.52 66.55
Apr-17 69.58 67.93 69.90 67.86
Apr-18 67.50 67.00 68.53 66.84

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.31 per share, and an increase next year of $1.28 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.